Genesis Drug Discovery & Development (GD3)
Genesis Drug Discovery & Development (GD3) Welcomes You!
Genesis Drug Discovery & Development (GD3) is a fully integrated, full-service CRO focused on providing services to support preclinical and clinical drug discovery programs of our clients throughout the drug discovery and development pipeline. The GD3 portfolio includes services for discovery biology, HTS and assay development, synthetic organic and medicinal chemistry, DMPK/in-vivo pharmacology, safety pharmacology, disease models, toxicology, and clinical trials services for the regulatory approval of novel drug and medical device products. We leverage decades of Pharma and CRO experience and expertise to advance your therapeutic programs to the benefit of patients and their physicians.